Targeted Therapy in Head and Neck Cancer: An Update on Current Clinical Developments in Epidermal Growth Factor Receptor-Targeted Therapy and Immunotherapies-Reference-Cited by-同舟云学术

Targeted Therapy in Head and Neck Cancer: An Update on Current Clinical Developments in Epidermal Growth Factor Receptor-Targeted Therapy and Immunotherapies

Published:2017-04-05 Issue:8 Volume:77 Page:843-857
ISSN:0012-6667
Container-title:Drugs
language:en
Short-container-title:Drugs

Author:

Moreira Jonathan,Tobias Alexander,O’Brien Michael P.,Agulnik Mark^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

http://link.springer.com/article/10.1007/s40265-017-0734-0/fulltext.html

Reference119 articles.

1. Davies L, Welch HG. Epidemiology of head and neck cancer in the United States. Otolaryngol Head Neck Surg. 2006;135:451–7.

2. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.

3. Seiwert TY, Cohen EE. State-of-the-art management of locally advanced head and neck cancer. Br J Cancer. 2005;92:1341–85.

4. Marur S, Forastiere AA. Head and neck cancer: changing epidemiology, diagnosis, and treatment. Mayo Clin Proc. 2008;83:489–501.

5. Sacco AG, Cohen EE. Current treatment options for recurrent or metastatic head and neck squamous cell carcinoma. J Clin Oncol. 2015;33:3305–13.

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Locally Invasive and Metastatic Eyelid Tumours;Oculoplastic, Lacrimal and Orbital Surgery;2024

2. Combination immunochemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: a systematic review and meta-analysis;BMJ Open;2023-06

3. Dissecting the functions of cancer-associated fibroblasts to therapeutically target head and neck cancer microenvironment;Biomedicine & Pharmacotherapy;2023-05

4. The story of EGFR: from signaling pathways to a potent anticancer target;Future Medicinal Chemistry;2022-09

5. Therapeutic approaches for the treatment of head and neck squamous cell carcinoma–An update on clinical trials;Translational Oncology;2022-07